Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Van T Hoang

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
BMC Cancer|March 9, 2019
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft modelMargarite D Matossian, Hope E Burks, Steven Elliott, et al.
Journal of Cellular Biochemistry|April 20, 2021
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulationVan T Hoang, Margarite D Matossian, Jacqueline La, et al.
Nature Communications|November 10, 2025
Distinct autoreactive CD19<sup>-</sup> plasma cell subsets accumulate in lupus-prone miceVan Duc Dang, Franziska Szelinski, Elodie Mohr, et al.
Journal of Agricultural and Food Chemistry|December 12, 2024
Context-Dependent Estrogenic Actions of (+)-Pisatin Produced in Elicited Green or Snow Pea (<i>Pisum sativum</i>)Jorge A Belgodere, Megan C Benz, G Wills Kpeli, et al.
Anti-Cancer Drugs|August 16, 2020
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathwaysMargarite D Matossian, Hope E Burks, Steven Elliott, et al.
Molecular Therapy. Oncology|March 11, 2026
Outcomes of point-of-care manufactured CAR T cell therapy for B cell acute lymphoblastic leukemia and non-Hodgkin lymphoma in VietnamLiem Thanh Nguyen, Duy D Nguyen, Quoc Khanh Bach, et al.
Breast Cancer Research and Treatment|February 3, 2018
A novel patient-derived xenograft model for claudin-low triple-negative breast cancerMargarite D Matossian, Hope E Burks, Annie C Bowles, et al.
Stem Cells Translational Medicine|June 3, 2021
Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cellsLiem Thanh Nguyen, Duc M Hoang, Kien T Nguyen, et al.
Frontiers in Oncology|August 28, 2020
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast CancerVan T Hoang, Margarite D Matossian, Deniz A Ucar, et al.
Journal of Natural Products|June 20, 2025
Modulation of Estrogen Receptor Activity by the Phytoalexin Tuberosin Produced from Elicited Kudzu (<i>Pueraria lobata</i>)Jorge A Belgodere, Jack R Elliott, Megan C Benz, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
BMC Cancer|March 9, 2019
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft modelMargarite D Matossian, Hope E Burks, Steven Elliott, et al.
Journal of Cellular Biochemistry|April 20, 2021
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulationVan T Hoang, Margarite D Matossian, Jacqueline La, et al.
Nature Communications|November 10, 2025
Distinct autoreactive CD19<sup>-</sup> plasma cell subsets accumulate in lupus-prone miceVan Duc Dang, Franziska Szelinski, Elodie Mohr, et al.
Journal of Agricultural and Food Chemistry|December 12, 2024
Context-Dependent Estrogenic Actions of (+)-Pisatin Produced in Elicited Green or Snow Pea (<i>Pisum sativum</i>)Jorge A Belgodere, Megan C Benz, G Wills Kpeli, et al.
Anti-Cancer Drugs|August 16, 2020
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathwaysMargarite D Matossian, Hope E Burks, Steven Elliott, et al.
Molecular Therapy. Oncology|March 11, 2026
Outcomes of point-of-care manufactured CAR T cell therapy for B cell acute lymphoblastic leukemia and non-Hodgkin lymphoma in VietnamLiem Thanh Nguyen, Duy D Nguyen, Quoc Khanh Bach, et al.
Breast Cancer Research and Treatment|February 3, 2018
A novel patient-derived xenograft model for claudin-low triple-negative breast cancerMargarite D Matossian, Hope E Burks, Annie C Bowles, et al.
Stem Cells Translational Medicine|June 3, 2021
Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cellsLiem Thanh Nguyen, Duc M Hoang, Kien T Nguyen, et al.
Frontiers in Oncology|August 28, 2020
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast CancerVan T Hoang, Margarite D Matossian, Deniz A Ucar, et al.
Journal of Natural Products|June 20, 2025
Modulation of Estrogen Receptor Activity by the Phytoalexin Tuberosin Produced from Elicited Kudzu (<i>Pueraria lobata</i>)Jorge A Belgodere, Jack R Elliott, Megan C Benz, et al.
Pageof 6